Panitumumab 100 mg/5 mL Suppliers & Bulk Manufacturers
Available Forms: Solution for Infusion
Available Strengths: 100 mg/5 mL
Reference Brands: Vectibix (USA/LATAM/India)
Category: Oncology Cancer Care
Panitumumab is a Oncology Cancer Care product available as Solution for Infusion in strengths 100 mg/5 mL. It corresponds to the reference brand Vectibix (USA/LATAM/India). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Panitumumab is a targeted anticancer medicine used in the treatment of metastatic colorectal cancer. It is a fully human monoclonal antibody that works as an epidermal growth factor receptor (EGFR) antagonist. EGFR is a protein found on the surface of some cancer cells that helps them grow, divide, and spread. By binding specifically to this receptor, panitumumab blocks the signals that promote tumor cell growth and survival. This targeted action helps slow or stop the progression of cancer in certain patients.
Panitumumab is commonly used as a single-agent therapy in patients with metastatic colorectal carcinoma whose disease has progressed after standard chemotherapy treatments such as fluoropyrimidine, oxaliplatin, and irinotecan. It is particularly effective in patients whose tumors have RAS wild-type status, as this genetic profile allows the drug to work more effectively against EGFR-driven tumor growth.
The medicine is administered as an intravenous infusion under medical supervision, usually in specialized oncology treatment settings. As a biologic therapy designed to target specific cancer pathways, panitumumab plays an important role in modern precision oncology, helping improve treatment outcomes and disease management for patients with advanced colorectal cancer.
Panitumumab — third party manufacturing & bulk supply
Panitumumab 100 mg/5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Panitumumab is supplied as Solution for Infusion — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Panitumumab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Panitumumab →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Panitumumab is used for the treatment of metastatic colorectal cancer, particularly in patients whose tumors express the epidermal growth factor receptor (EGFR) and have RAS wild-type genes. It is often used when the cancer has progressed after other treatments or in combination with certain chemotherapy regimens.
Panitumumab is a fully human monoclonal antibody produced using recombinant DNA technology in mammalian cell cultures. It is designed to specifically target and bind to the EGFR protein found on the surface of some cancer cells.
The primary trade name of Panitumumab is Vectibix.
Panitumumab (Vectibix) is developed and marketed by Amgen.
The generic name is Panitumumab.
The main brand name is Vectibix.
Panitumumab is manufactured in GMP-certified biologics manufacturing facilities approved by major regulatory authorities such as the US FDA and EMA, with production handled by the innovator company and authorized manufacturing partners depending on global supply requirements.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
